280 related articles for article (PubMed ID: 35874760)
21. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma.
Dong W; Xie Y; Huang H
Front Endocrinol (Lausanne); 2022; 13():884777. PubMed ID: 35733776
[TBL] [Abstract][Full Text] [Related]
22. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
23. Identifying Explainable Machine Learning Models and a Novel SFRP2
Yang Z; Zhou D; Huang J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069266
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
An Y; Yang Q
Biomed Res Int; 2020; 2020():7594098. PubMed ID: 33381581
[TBL] [Abstract][Full Text] [Related]
25. Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression.
Yang Z; Yang X; Xu S; Jin P; Li X; Wei X; Liu D; Huang K; Long S; Wang Y; Sun C; Chen G; Hu J; Meng L; Ma D; Gao Q
Mol Cancer; 2017 Oct; 16(1):163. PubMed ID: 29041931
[TBL] [Abstract][Full Text] [Related]
26. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
Zheng H; Liu H; Li H; Dou W; Wang X
Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
[No Abstract] [Full Text] [Related]
27. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
28. Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma.
Gu Y; Zhuo H
Aging Male; 2023 Dec; 26(1):2233609. PubMed ID: 37428096
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis from multi-center studies identifies a weighted gene co-expression network analysis-based Tregs signature in ovarian cancer.
Cao Y; Liu YL; Lu XY; Kai HL; Han Y; Zheng YL
Environ Toxicol; 2024 Feb; 39(2):736-750. PubMed ID: 37713585
[TBL] [Abstract][Full Text] [Related]
30. SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma.
Liu CL; Pan HW; Torng PL; Fan MH; Mao TL
Oncol Rep; 2019 Dec; 42(6):2706-2715. PubMed ID: 31638245
[TBL] [Abstract][Full Text] [Related]
31. GLIS1 in Cancer-Associated Fibroblasts Regulates the Migration and Invasion of Ovarian Cancer Cells.
Kim MJ; Jung D; Park JY; Lee SM; An HJ
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216340
[TBL] [Abstract][Full Text] [Related]
32. Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer.
Zeng L; Wang X; Wang F; Zhao X; Ding Y
Front Genet; 2022; 13():925231. PubMed ID: 35873482
[TBL] [Abstract][Full Text] [Related]
33. Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co-expression network analysis.
Xu Y; Zhang Z; Zhang L; Zhang C
Breast Cancer; 2020 Sep; 27(5):1017-1028. PubMed ID: 32383139
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract][Full Text] [Related]
35. A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning.
Zhao B; Pei L
BMC Med Genomics; 2023 Oct; 16(1):230. PubMed ID: 37784081
[TBL] [Abstract][Full Text] [Related]
36. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
37. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
38. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
39. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
40. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
